{"id":"https://openalex.org/W2052329109","doi":"https://doi.org/10.1185/03007990802212981","title":"Evolving concepts of type 2 diabetes management with oral medications: new approaches to an old disease","display_name":"Evolving concepts of type 2 diabetes management with oral medications: new approaches to an old disease","publication_year":2008,"publication_date":"2008-06-24","ids":{"openalex":"https://openalex.org/W2052329109","doi":"https://doi.org/10.1185/03007990802212981","mag":"2052329109","pmid":"https://pubmed.ncbi.nlm.nih.gov/18573228"},"language":"en","primary_location":{"id":"doi:10.1185/03007990802212981","doi":"https://doi.org/10.1185/03007990802212981","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007990802212981","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045462483","display_name":"Robert R. Henry","orcid":"https://orcid.org/0000-0002-4821-0117","observed_orcids":["https://orcid.org/0000-0002-4821-0117"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert R. Henry","raw_affiliation_strings":["University of California, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, CA, USA","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5045462483"],"corresponding_institution_ids":["https://openalex.org/I36258959"],"apc_list":null,"apc_paid":null,"fwci":0.3813,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.31279621,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"24","issue":"8","first_page":"2189","last_page":"2202"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9929999709129333},{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.9829999804496765},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.6769999861717224},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9829999804496765},{"id":"https://openalex.org/keywords/bile-acid-sequestrants","display_name":"bile acid sequestrants","score":1.0},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9399999976158142},{"id":"https://openalex.org/keywords/glycogenolysis","display_name":"glycogenolysis","score":0.878000020980835},{"id":"https://openalex.org/keywords/gluconeogenesis","display_name":"gluconeogenesis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.8050000071525574},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8169999718666077},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/vascular-complications","display_name":"vascular complications","score":0.47699999809265137},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7590000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9793010950088501},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8720289468765259},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.8059538006782532},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7910864353179932},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7349145412445068},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5997351408004761},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5752298831939697},{"id":"https://openalex.org/C2778848681","wikidata":"https://www.wikidata.org/wiki/Q6725716","display_name":"Macrovascular disease","level":4,"score":0.49893760681152344},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37534886598587036},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1650046706199646}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D043884","descriptor_name":"Receptor, Cannabinoid, CB1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1185/03007990802212981","doi":"https://doi.org/10.1185/03007990802212981","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007990802212981","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:18573228","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18573228","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W47644979","https://openalex.org/W165619514","https://openalex.org/W1541662874","https://openalex.org/W1971471384","https://openalex.org/W1973383046","https://openalex.org/W1975588287","https://openalex.org/W1977351228","https://openalex.org/W1977619586","https://openalex.org/W1982990554","https://openalex.org/W1984588810","https://openalex.org/W1984645352","https://openalex.org/W1986971321","https://openalex.org/W1989976483","https://openalex.org/W1991565451","https://openalex.org/W1994598079","https://openalex.org/W2008165628","https://openalex.org/W2020090912","https://openalex.org/W2020638064","https://openalex.org/W2027249582","https://openalex.org/W2033720203","https://openalex.org/W2042180479","https://openalex.org/W2046645679","https://openalex.org/W2047353065","https://openalex.org/W2048837894","https://openalex.org/W2051462052","https://openalex.org/W2056132862","https://openalex.org/W2058778081","https://openalex.org/W2062679938","https://openalex.org/W2069106703","https://openalex.org/W2078089300","https://openalex.org/W2085862152","https://openalex.org/W2087587748","https://openalex.org/W2090727292","https://openalex.org/W2093303670","https://openalex.org/W2098832491","https://openalex.org/W2102312517","https://openalex.org/W2107620454","https://openalex.org/W2118479946","https://openalex.org/W2123907272","https://openalex.org/W2127125241","https://openalex.org/W2139442251","https://openalex.org/W2145335273","https://openalex.org/W2150654293","https://openalex.org/W2153449155","https://openalex.org/W2160967602","https://openalex.org/W2165274499","https://openalex.org/W2165284792","https://openalex.org/W2167621077","https://openalex.org/W2170913795","https://openalex.org/W2171512247","https://openalex.org/W2188846692","https://openalex.org/W2337454357","https://openalex.org/W2411925284","https://openalex.org/W2527670279","https://openalex.org/W4210559565"],"related_works":["https://openalex.org/W2613715913","https://openalex.org/W1479760405","https://openalex.org/W4387941492","https://openalex.org/W1988527288","https://openalex.org/W2543415957","https://openalex.org/W2159390850","https://openalex.org/W3029563297","https://openalex.org/W2069935741","https://openalex.org/W2106178925","https://openalex.org/W2196820307"],"abstract_inverted_index":{"BACKGROUND:":[0],"Type":[1,27],"2":[2,28,57,78,120,146,215],"diabetes":[3,29,58,147,216,225],"is":[4],"often":[5],"accompanied":[6],"by":[7],"co-morbid":[8],"conditions":[9,53],"such":[10],"as":[11,87],"hypertension":[12],"and":[13,24,37,43,51,89,101,130,174,202,224],"dyslipidemia,":[14],"which,":[15],"coupled":[16],"with":[17,55,92,122],"persistent":[18],"hyperglycemia,":[19,35],"result":[20],"in":[21,61,90,116,141,197,218],"significant":[22],"macrovascular":[23],"microvascular":[25],"complications.":[26,45],"treatments":[30,240],"focus":[31,124],"primarily":[32],"on":[33,70,106,113,125,132,166],"controlling":[34],"hypertension,":[36],"dyslipidemia":[38],"to":[39,97,244],"stabilize":[40],"the":[41,52,62,71,103,149,231,242],"disease":[42,104],"minimize":[44],"Despite":[46],"treatment,":[47],"control":[48,100],"of":[49,64,73,128,210,233,238],"hyperglycemia":[50],"associated":[54],"type":[56,77,119,145,214],"are":[59,204,217],"suboptimal":[60],"majority":[63],"patients.":[65,107],"Research":[66],"efforts":[67],"have":[68],"concentrated":[69],"development":[72,117,143],"new":[74],"therapies":[75,193,212],"for":[76,118,144,160,213,230],"diabetes,":[79,121],"including":[80],"agents":[81,96,115,140],"that":[82],"could":[83],"be":[84],"used":[85],"both":[86],"monotherapy":[88],"combination":[91],"established":[93],"oral":[94,114,139],"antidiabetic":[95],"improve":[98,246],"glycemic":[99],"reduce":[102],"burden":[105],"OBJECTIVE:":[108],"To":[109],"review":[110,155],"published":[111,180],"literature":[112,154],"a":[123,153],"their":[126],"mechanism":[127],"action":[129],"impact":[131],"concomitant":[133],"risk":[134],"factors.":[135],"METHODS:":[136],"After":[137],"identifying":[138],"late-stage":[142],"using":[148],"R&D":[150],"Insight":[151],"database,":[152],"was":[156],"conducted":[157],"through":[158],"PubMed":[159],"studies":[161],"(preferably":[162],"randomized,":[163],"controlled":[164],"trials)":[165],"dipeptidyl":[167],"peptidase-IV":[168],"inhibitors,":[169],"CB(1)":[170],"cannabinoid":[171],"receptor":[172],"blockers,":[173],"bile":[175],"acid":[176],"sequestrants.":[177],"Where":[178],"limited":[179],"data":[181],"were":[182,189],"available,":[183],"abstracts":[184],"from":[185],"recent":[186],"major":[187],"conferences":[188],"searched.":[190],"Other":[191],"emerging":[192],"targeting":[194],"pathways":[195],"involved":[196],"modifying":[198],"insulin":[199],"resistance,":[200],"glycogenolysis,":[201],"gluconeogenesis":[203],"also":[205],"discussed.":[206],"CONCLUSIONS:":[207],"A":[208],"variety":[209],"novel":[211],"development,":[219],"which":[220],"will":[221],"provide":[222],"patients":[223],"care":[226],"providers":[227],"more":[228],"choices":[229],"management":[232],"this":[234],"disease.":[235],"Importantly,":[236],"many":[237],"these":[239],"offer":[241],"potential":[243],"significantly":[245],"multiple":[247],"metabolic":[248],"parameters.":[249]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}